US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

25.91

+0.21000.82%

Post-market: 25.910.00000.00%16:10 EST

Volume:177.14K

Turnover:4.60M

Market Cap:428.18M

PE:-1.24

High:27.16

Open:26.43

Low:24.97

Close:25.70

52wk High:74.07

52wk Low:12.86

Shares:16.53M

Float Shares:5.58M

Volume Ratio:0.92

T/O Rate:3.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.9031

EPS(LYR):-101.9248

ROE:-646.34%

ROA:0.96%

PB:-4.20

PE(LYR):-0.25

Loading ...

Overview Company News Filings

Press Release: Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call

Claritev Corporation to Release Q4 and Fiscal Year 2025 Results and Host Earnings Call

Claritev enters strategic relationship with Kinetiq Health

Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty

THOMSON REUTERS

Claritev Corporation Partners with Kinetiq Health to Enhance Healthcare Cost Management

Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Simply Wall St.

Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target

MT Newswires Live

Claritev Is Maintained at Buy by Citigroup

Claritev Initiated at Equal-Weight by Wells Fargo

Claritev price target lowered to $63 from $80 at Citi

Claritev Corp : Wells Fargo Initiates Coverage With Equal Weight Rating; Price Target $33

THOMSON REUTERS

Claritev Corporation to Present at J.P. Morgan Healthcare Conference

Press Release: Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Claritev Corporation to Present at Major Healthcare and Finance Conferences

Claritev CEO Travis Dalton Acquires Common Shares

Claritev SVP William B. Mintz Reports Acquisition of Common Shares

Claritev EVP Chief Digital Officer Michael Kim Acquires Common Shares

Claritev SVP and General Counsel Tara O'Neil Acquires Common Shares

Piper Sandler Reaffirms Their Buy Rating on Claritev (CTEV)

H&F Corporate Investors VIII Reports Disposal of Claritev Corporation Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTEV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":25.91,"timestamp":1770411600000,"preClose":25.7,"halted":0,"volume":177140,"hourTrading":{"tag":"盘后","latestPrice":25.91,"preClose":25.91,"latestTime":"16:10 EST","volume":1776,"amount":46016.16,"timestamp":1770412204755,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008171206225680967,"floatShares":5577143,"shares":16525644,"eps":-20.903133,"marketStatus":"Closed","change":0.21,"latestTime":"02-06 16:00:00 EST","open":26.43,"high":27.16,"low":24.97,"amount":4599719.44271,"amplitude":0.085214,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.903133,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":25.7,"postHourTrading":{"tag":"盘后","latestPrice":25.91,"preClose":25.91,"latestTime":"16:10 EST","volume":1776,"amount":46016.16,"timestamp":1770412204755,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.920717,"impliedVol":0.9337,"impliedVolPercentile":0.3376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5577143,"roa":"0.96%","roe":"-646.34%","lyrEps":-101.92478,"volumeRatio":0.920717,"shares":16525644,"dividePrice":0,"high":27.16,"amplitude":0.085214,"preClose":25.7,"low":24.97,"week52Low":12.86,"pbRate":"-4.20","psRate":"0.45","week52High":74.0699,"institutionHeld":0,"latestPrice":25.91,"eps":-20.903133,"divideRate":0,"volume":177140,"delay":0,"ttmEps":-20.903133,"open":26.43,"prevYearClose":42.75,"prevWeekClose":27.16,"prevMonthClose":27.16,"prevQuarterClose":42.75,"earningDate":1771776000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"date":"2026-02-23","symbol":"CTEV","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-3.96,"defaultRemindTime":1771880400000,"name":null,"time":"Post Market","dateTimestamp":1771822800000,"actualEps":null},{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32},{"market":"US","date":"2025-05-08","symbol":"CTEV","fiscalQuarterEnding":"2025/03","expectedEps":-2.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-3.43},{"market":"US","date":"2025-02-25","symbol":"CTEV","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-5.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1768194000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2026-02-05","current":-1.267753,"percent":0.525641,"low":-3.349365,"twenty":-1.723394,"median":-1.277756,"eighty":-0.2265,"high":-0.170756,"avg":-1.085625,"sd":0.718726,"marketCap":416446228},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464},{"date":"2025-11-21","current":-2.187607,"twenty":-1.633144,"median":-0.596754,"eighty":-0.215261,"marketCap":747454878},{"date":"2025-11-28","current":-2.615165,"twenty":-1.640942,"median":-0.60834,"eighty":-0.216127,"marketCap":893541571},{"date":"2025-12-05","current":-1.787134,"twenty":-1.682416,"median":-0.609806,"eighty":-0.216422,"marketCap":610622545},{"date":"2025-12-12","current":-1.88435,"twenty":-1.687561,"median":-0.622299,"eighty":-0.217741,"marketCap":643839090},{"date":"2025-12-19","current":-1.988338,"twenty":-1.707649,"median":-0.634165,"eighty":-0.218607,"marketCap":679369224},{"date":"2025-12-26","current":-2.064756,"twenty":-1.732682,"median":-0.647217,"eighty":-0.219198,"marketCap":705479742},{"date":"2026-01-02","current":-2.067658,"twenty":-1.769935,"median":-0.66969,"eighty":-0.220083,"marketCap":706471281},{"date":"2026-01-09","current":-1.509511,"twenty":-1.763775,"median":-0.697121,"eighty":-0.220595,"marketCap":515765349},{"date":"2026-01-16","current":-1.45389,"twenty":-1.7451,"median":-1.219145,"eighty":-0.221029,"marketCap":496760858},{"date":"2026-01-23","current":-1.453407,"twenty":-1.733974,"median":-1.267698,"eighty":-0.222131,"marketCap":496595602},{"date":"2026-01-30","current":-1.302504,"twenty":-1.730745,"median":-1.277756,"eighty":-0.226264,"marketCap":445035592},{"date":"2026-02-05","current":-1.21883,"twenty":-1.723394,"median":-1.277756,"eighty":-0.2265,"marketCap":416446228}],"updateTime":1770393565921},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607087226","title":"Press Release: Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087226?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:02","pubTimestamp":1769691720,"startTime":"0","endTime":"0","summary":"Claritev Corporation  , a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time.Claritev is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by multiple data sources and over 40 years of claims experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose--built solutions that support all key players -- including pa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2607087620","title":"Claritev Corporation to Release Q4 and Fiscal Year 2025 Results and Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087620?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:00","pubTimestamp":1769691649,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL2mC2by:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2605071781","title":"Claritev enters strategic relationship with Kinetiq Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2605071781","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605071781?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:17","pubTimestamp":1769001425,"startTime":"0","endTime":"0","summary":"Claritev (CTEV) announced a strategic relationship with Kinetiq Health. The combined offering delivers monthly medical and pharmacy claims surveill...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-enters-strategic-relationship-with-kinetiq-health-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-enters-strategic-relationship-with-kinetiq-health-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2605449102","title":"Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2605449102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605449102?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000423,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM0PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2605101738","title":"Claritev Corporation Partners with Kinetiq Health to Enhance Healthcare Cost Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2605101738","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605101738?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:15","pubTimestamp":1768997743,"startTime":"0","endTime":"0","summary":"Claritev Corporation has announced a strategic partnership with Kinetiq Health to enhance cost management and advance claims surveillance and diagnostic certainty in healthcare. The collaboration will integrate Kinetiq Health's risk management services with Claritev's BenInsights analytics platform, aiming to help employers, brokers, TPAs, and health plans identify high-cost medical and pharmacy risks earlier, improve diagnostic accuracy, and achieve better financial outcomes. The partnership is designed to deliver value through earlier risk identification, greater diagnostic confidence, and improved cost management for organizations across the healthcare sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation publi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL56nNJc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2604024976","title":"Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2604024976","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604024976?lang=en_us&edition=fundamental","pubTime":"2026-01-18 20:44","pubTimestamp":1768740240,"startTime":"0","endTime":"0","summary":"Unfortunately for some shareholders, the Claritev Corporation ( NYSE:CTEV ) share price has dived 26% in the last...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ctev/claritev/news/claritev-corporation-nysectev-looks-inexpensive-after-fallin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ctev/claritev/news/claritev-corporation-nysectev-looks-inexpensive-after-fallin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CTEV","BK4167","NYSE"],"gpt_icon":0},{"id":"2602173385","title":"Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2602173385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602173385?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:40","pubTimestamp":1768221634,"startTime":"0","endTime":"0","summary":"Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2602331370","title":"Claritev Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2602331370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602331370?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:04","pubTimestamp":1767974640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 09, 2026 11:04 ET (16:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2602737929","title":"Claritev Initiated at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602737929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602737929?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:51","pubTimestamp":1767966660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 09, 2026 08:51 ET (13:51 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","LU0208291251.USD","LU0070302665.USD","IE00B7SZLL34.SGD","LU0211328371.USD","LU0289960550.SGD","LU2361044865.SGD","LU0106831901.USD","LU0128525689.USD","LU0211327993.USD","LU0417517546.SGD","LU0314106906.USD","LU1280957306.USD","LU0029864427.USD","LU0942090050.USD","LU0072461881.USD","LU0310799852.SGD","LU1506573853.SGD","CTEV","BK4588","LU0175139822.USD","LU0154236417.USD","BK4207","LU0130517989.USD","LU0742534661.SGD","LU0787776722.HKD","LU2236285917.USD","BK4167","LU0128525929.USD","LU1267930573.SGD","LU0640476718.USD","LU1791807156.HKD","BK4585","LU1814569148.SGD","LU0320765489.SGD","LU0267386448.USD","LU0310800379.SGD","LU1069347547.HKD","LU0868494617.USD","LU1894683348.USD","LU2361045086.USD","LU0048573561.USD","LU1267930490.SGD","LU2461242641.AUD","IE00B19Z3B42.SGD","BK4559","LU2361044949.HKD","IE00B19Z3581.USD","LU0648001328.SGD","LU0052756011.USD"],"gpt_icon":0},{"id":"2602736633","title":"Claritev price target lowered to $63 from $80 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2602736633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602736633?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:16","pubTimestamp":1767960979,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on Claritev (CTEV) to $63 from $80 and keeps a Buy rating on the shares as part of the firm’s 2026 outlook not...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-lowered-to-63-from-80-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-lowered-to-63-from-80-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2602203933","title":"Claritev Corp : Wells Fargo Initiates Coverage With Equal Weight Rating; Price Target $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2602203933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602203933?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:28","pubTimestamp":1767958138,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA115:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2601895859","title":"Claritev Corporation to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601895859","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601895859?lang=en_us&edition=fundamental","pubTime":"2026-01-06 18:00","pubTimestamp":1767693611,"startTime":"0","endTime":"0","summary":"Claritev Corporation will participate in the 44th Annual J.P. Morgan Healthcare Conference, with management presenting on Thursday, January 15, 2026, at 7:30 a.m. PT. A live webcast and audio archive of the presentation will be available through the investor relations section of Claritev's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on January 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL3Tb8bn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2591847929","title":"Press Release: Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2591847929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591847929?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:00","pubTimestamp":1765890000,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., Dec. 16, 2025  -- Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, providing up to $77.5 million in principal amount of new financing. The credit agreement, which has a term of four years, includes an initial tranche of $40 million fully funded at close, and an additional two tranches of up to an aggregate of $37.5 million available to Humacyte, subject to the satisfaction of certain revenue, regulatory approvals, liquidity conditions and, in the case of the third tranche, lender approvals. Proceeds from the initial $40 million tranche have been used primarily to retire Humacyte's existing debt facility.\"We are excited to partner with Humacyte as it embarks on its next chapter of growth. Symvess is addressing significant patient need","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4167","CTEV","BK4022","R","BK4563","BK4139","BK4232"],"gpt_icon":0},{"id":"2585625144","title":"Claritev Corporation to Present at Major Healthcare and Finance Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2585625144","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585625144?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989241,"startTime":"0","endTime":"0","summary":"Claritev Corporation will participate in several upcoming conferences in December 2025. The company's management team will attend the BofA Securities Leveraged Finance Conference on December 2 at The Boca Raton in Florida, Citi's 2025 Global Healthcare Conference on December 3 at the Intercontinental Miami, and the Piper Sandler 37th Annual Healthcare Conference on December 4 at the Lotte New York Palace in New York, featuring a fireside chat at 8:00 am Eastern Time. Live webcasts and audio archives of the events will be available on the investor relations section of Claritev's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL7V6yzb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU0306806265.USD","CTEV","LU1363072403.SGD","LU0314106906.USD","LU2265009873.SGD","LU0787776722.HKD","LU0256863811.USD","LU1069347547.HKD","LU1201861165.SGD","LU1496350171.SGD","LU1506573853.SGD","LU1366192091.USD","LU0170899867.USD","LU0868494617.USD","LU1668664300.SGD","LU0648000940.SGD","LU1201861249.SGD","LU0052756011.USD","LU1035773651.USD","LU0980610538.SGD","LU2129689431.USD","LU1880398471.USD","LU0130517989.USD","IE00BLSP4239.USD","LU0648001328.SGD","LU0070302665.USD","IE0002270589.USD","LU1162221912.USD","BAC","BK4585","LU0477156953.USD","LU0106831901.USD","LU0310800965.SGD","LU0098860793.USD","LU0640476718.USD","IE00BBT3K403.USD","LU1804176565.USD","LU0971096721.USD","LU0234572021.USD","LU1267930227.SGD","BK4504","LU1894683348.USD","IE00B19Z3B42.SGD","IE00B1BXHZ80.USD","BK4553","LU0306807586.USD","LU1880398554.USD","LU0321505868.SGD","LU0683600562.USD"],"gpt_icon":0},{"id":"2585416526","title":"Claritev CEO Travis Dalton Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585416526","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585416526?lang=en_us&edition=fundamental","pubTime":"2025-11-21 07:16","pubTimestamp":1763680574,"startTime":"0","endTime":"0","summary":"Travis Dalton, President, CEO, and Executive Chair of Claritev Corporation, has reported the acquisition of Class A common shares of Claritev Corporation, according to a recent SEC Form 4 filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL7zJjms:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev CEO Travis Dalton Acquires Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2584765799","title":"Claritev SVP William B. Mintz Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584765799","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584765799?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:34","pubTimestamp":1763588081,"startTime":"0","endTime":"0","summary":"William B. Mintz, Senior Vice President and Chief Strategy Officer of Claritev Corporation, reported the acquisition of Class A common shares of Claritev Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL98pNM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Claritev SVP William B. Mintz Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2584663889","title":"Claritev EVP Chief Digital Officer Michael Kim Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584663889","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584663889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:23","pubTimestamp":1763501016,"startTime":"0","endTime":"0","summary":"Michael Kim, EVP and Chief Digital Officer of Claritev Corporation, reported the acquisition of Class A common shares of Claritev Corporation, according to a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL9fJx08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev EVP Chief Digital Officer Michael Kim Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2584966800","title":"Claritev SVP and General Counsel Tara O'Neil Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584966800","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584966800?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:23","pubTimestamp":1763500997,"startTime":"0","endTime":"0","summary":"Tara O'Neil, Senior Vice President and General Counsel of Claritev Corporation, reported the acquisition of Class A common shares of Claritev Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL7CQfLq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2584934591","title":"Piper Sandler Reaffirms Their Buy Rating on Claritev (CTEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584934591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584934591?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:47","pubTimestamp":1763466434,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Jessica Tassan maintained a Buy rating on Claritev today and set a price target of $90.00. According to TipRanks, Tassan is a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-claritev-ctev-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-claritev-ctev-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV"],"gpt_icon":0},{"id":"2583071684","title":"H&F Corporate Investors VIII Reports Disposal of Claritev Corporation Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583071684","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583071684?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:38","pubTimestamp":1763156331,"startTime":"0","endTime":"0","summary":"H&F Corporate Investors VIII, Ltd. has reported the disposal of common shares of Claritev Corporation, according to a recent Form 4 filing with the U.S. Securities and Exchange Commission. The filing was made by H&F Corporate Investors VIII, Ltd., along with other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL58wtvP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"H&F Corporate Investors VIII Reports Disposal of Claritev Corporation Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}]}}